WIPOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die Internationale Marke SUMITOVANT BIOPHARMA wurde als Wortmarke am 27.12.2019 bei der Weltorganisation für geistiges Eigentum angemeldet.
| Markenform | Wortmarke |
| Aktenzeichen | 1525006 |
| Länder | 
|
| Basismarke |
Nr. 2019-147713,
22. November 2019
|
| Anmeldedatum | 27. Dezember 2019 |
| Ablaufdatum | 27. Dezember 2029 |
Markeninhaber
6-8, Doshomachi 2-chome,
Chuo-ku, Osaka-shi
JP
Chuo-ku, Osaka-shi
JP
Markenvertreter
AOYAMA & PARTNERS,
Umeda Hankyu Bldg. Office Tower,
JP
Waren und Dienstleistungen
05
Pharmaceutical preparations; pharmaceutical preparations for
human use; biological preparations for medical and
therapeutic purposes
09
Calculating machines; data processing apparatus; computers;
computer hardware; computer peripherals; computer software;
computer programs; computer software for analytics in the
fields of public health, healthcare, biomedical research;
software for analytics for clinical trial data
35
Advertising; publicity agency services; business management;
business management assistance; business administration;
business consulting services; secretarial services; office
functions; business research; providing business
information; marketing research; market analysis services;
provision of market research information; marketing
services; compiling of information into computer databases;
updating and maintenance of data in computer databases;
business data analysis; assistance, advisory services and
consultancy with regard to business analysis, in the field
of healthcare, biomedical and pharmaceutical research and
pharmaceutical preparations; statistical analysis;
statistical analysis and reporting in the field of
healthcare, biomedical and pharmaceutical research and
pharmaceutical preparations; statistical analysis relating
to healthcare data, biomedical and pharmaceutical research
and clinical trial data; business analysis in the field of
healthcare, biomedical and pharmaceutical research and
pharmaceutical preparations; systematization of data in
computer databases
42
Consultancy relating to technical and scientific analysis;
medical research; chemistry services; clinical trials;
analysis of technical data; testing, inspection or research
of pharmaceuticals, cosmetics or foodstuffs; providing
medical and scientific research information relating to
clinical trials of pharmaceuticals; research in the field of
pharmaceutical and biologic therapeutic products; providing
information relating to testing, inspection or research of
pharmaceuticals; cloud computing; provision of information
and data relating to scientific and technological research
and development; rental of computers; providing computer
programs on data networks; software as a service [SaaS];
computer software design, computer programming, or
maintenance of computer software
44
Provision of medical information; providing health
information; providing medical information from a web site;
providing healthcare information from a web site; health
counselling; provision of medical information relating to
pharmaceutical and biologic therapeutic products
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
Markenhistorie
| Datum | Belegnummer | Bereich | Eintrag |
|---|---|---|---|
| 20. Juli 2023 | 2023/29 Gaz | PH | RAW: Total Invalidation |
| 25. August 2022 | 2022/38 Gaz | KH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 19. Mai 2022 | 2022/24 Gaz | MX | Ablehnung |
| 10. Mai 2022 | 2022/19 Gaz | US | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 22. Februar 2022 | 2022/11 Gaz | LA | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 14. Dezember 2021 | 2021/51 Gaz | LA | Ablehnung |
| 01. November 2021 | 2021/44 Gaz | MY | Ablehnung |
| 06. Oktober 2021 | 2021/41 Gaz | KR | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 23. September 2021 | 2021/40 Gaz | TH | Ablehnung |
| 09. September 2021 | 2021/38 Gaz | KH | Ablehnung |
| 19. August 2021 | 2021/33 Gaz | TR | Ablehnung |
| 11. August 2021 | 2021/33 Gaz | CA | Ablehnung |
| 09. Juni 2021 | 2021/23 Gaz | VN | Ablehnung |
| 04. Juni 2021 | 2021/23 Gaz | IS | Ablehnung |
| 16. Mai 2021 | 2021/24 Gaz | PH | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 30. April 2021 | 2021/17 Gaz | NZ | RAW: Rule 18ter(2)(i) GP following a provisional refusal |
| 01. April 2021 | 2021/14 Gaz | LI | Ablehnung |
| 01. April 2021 | 2021/14 Gaz | UA | Ablehnung |
| 23. März 2021 | 2021/12 Gaz | NO | Ablehnung |
| 01. März 2021 | 2021/9 Gaz | ID | Ablehnung |
| 11. Februar 2021 | 2021/6 Gaz | CH | Ablehnung |
| 01. Februar 2021 | 2021/5 Gaz | KR | Ablehnung |
| 05. Januar 2021 | 2021/1 Gaz | BR | Ablehnung |
| 29. Dezember 2020 | 2020/53 Gaz | RU | RAW: Rule 18ter(2)(ii) GP following a provisional refusal |
| 14. Dezember 2020 | 2020/51 Gaz | IN | Ablehnung |
| 21. November 2020 | 2020/48 Gaz | CO | Ablehnung |
| 06. November 2020 | 2020/45 Gaz | SG | Ablehnung |
| 17. September 2020 | 2020/38 Gaz | AU | Ablehnung |
| 11. September 2020 | 2020/38 Gaz | RU | Ablehnung |
| 02. September 2020 | 2020/36 Gaz | EM | Ablehnung |
| 02. September 2020 | 2020/37 Gaz | NZ | Ablehnung |
| 28. August 2020 | 2020/35 Gaz | GB | Ablehnung |
| 20. August 2020 | 2020/34 Gaz | CN | Ablehnung |
| 26. Juni 2020 | 2020/28 Gaz | PH | Ablehnung |
| 28. April 2020 | 2020/18 Gaz | US | Ablehnung |
| 27. Dezember 2019 | JP | Eintragung |
ID: 141525006